An economic analysis performed by York Health Economics consortium (YHEC)1 revealed that DAFNE would pay for itself within 4-5 years due to the reduced complication rate expected due to improved glycaemic control. A lay summary of this published economics paper is available below.
Audit of both local and national DAFNE outcome data2 have been performed demonstrating significant improvement in glycaemic control, with a reduction in incidence of severe hypoglycaemia, diabetic ketoacidosis and prevalence of impaired hypoglycaemia awareness.3 The reduction in acute events provides short-term financial gains, particularly in reduced paramedic call-out and admissions.4 Furthermore, the audit showed significantly improved anxiety and depression scores.5
These are regularly updated (minimum every 3 years) to ensure up to date evidence based information is being passed onto patients in the most effective way. DAFNE centres receive a free copy of all updated educator resources free of charge.
A diabetes unit that offers DAFNE becomes a member of the DAFNE Collaborative and benefits from a national infrastructure and receives support from the Central DAFNE admin office. Further details of this support can be found on page 2 of DAFNE Fact Sheet Three and in Fact Sheet Ten.
Last Updated: 04/11/2011